Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ABT
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Mary K. Moreland Officer | ABT Abbott Laboratories | 3,500 | $406.0K | — | Nov 5, 2026 | Form 4 ↗ 1 day later · 3,500 shares | Form 144 ↗ |
| Sep 2, 2026 | John A. McCoy, Jr. Officer | ABT Abbott Laboratories | 27 | $2,957 | — | Sep 2, 2026 | Form 4 ↗ 1 day later · 27 shares | Form 144 ↗ |
| Aug 25, 2026 | Robert B. Ford Officer, Director | ABT Abbott Laboratories | 398,832 | $46.2M | — | Aug 25, 2026 | Form 4 ↗ 2 days later · 398,832 shares | Form 144 ↗ |
| Aug 11, 2026 | Louis H. Morrone Officer | ABT Abbott Laboratories | 5,850 | $642.5K | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 5,850 shares | Form 144 ↗ |
| May 15, 2026 | Robert J. Alpern Retired Director | ABT Abbott Laboratories | 7,587 | $646.8K | — | May 15, 2026 | — | Form 144 ↗ |
| Apr 27, 2026 | Robert J. Alpern Retired Director | ABT Abbott Laboratories | 29,211 | $2.7M | — | Apr 27, 2026 | — | Form 144 ↗ |
| Mar 2, 2026 | Elizabeth C. Cushman Officer | ABT Abbott Laboratories | 263 | $30.4K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 263 shares | Form 144 ↗ |
| Mar 2, 2026 | Eric Shroff Officer | ABT Abbott Laboratories | 709 | $81.9K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 709 shares | Form 144 ↗ |
| Mar 2, 2026 | Louis H. Morrone Officer | ABT Abbott Laboratories | 1,144 | $132.2K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 1,144 shares | Form 144 ↗ |
| Mar 2, 2026 | Mary K. Moreland Officer | ABT Abbott Laboratories | 613 | $70.8K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 613 shares | Form 144 ↗ |
| Mar 2, 2026 | John A. McCoy, Jr. Officer | ABT Abbott Laboratories | 585 | $67.6K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 585 shares | Form 144 ↗ |
| Mar 2, 2026 | Daniel Gesua Sive Salvadori Officer | ABT Abbott Laboratories | 885 | $102.3K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 885 shares | Form 144 ↗ |
| Nov 25, 2025 | Eric Shroff Officer | ABT Abbott Laboratories | 1,586 | $203.0K | — | Nov 25, 2025 | Form 4 ↗ same day · 1,586 shares | Form 144 ↗ |
| Aug 8, 2025 | Philip P. Boudreau Officer | ABT Abbott Laboratories | 5,550 | $746.8K | — | Aug 8, 2025 | Form 4 ↗ 3 days later · 5,550 shares | Form 144 ↗ |
| Apr 30, 2025 | Sally E Blount Director | ABT Abbott Laboratories | 2,600 | $337.1K | — | Apr 30, 2025 | Form 4 ↗ 2 days later · 2,600 shares | Form 144 ↗ |
| Mar 7, 2025 | Lisa D. Earnhardt Officer | ABT Abbott Laboratories | 200 | $27.3K | — | Mar 7, 2025 | Form 4 ↗ same day · 91,367 shares | Form 144 ↗ |
| Mar 6, 2025 | Lisa D. Earnhardt Officer | ABT Abbott Laboratories | 91,167 | $12.2M | — | Mar 6, 2025 | Form 4 ↗ 1 day later · 91,367 shares | Form 144 ↗ |
| Mar 3, 2025 | Eric Shroff Officer | ABT Abbott Laboratories | 562 | $77.7K | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 562 shares | Form 144 ↗ |
| Mar 3, 2025 | Andrea F. Wainer Retired Officer | ABT Abbott Laboratories | 949 | $131.1K | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 949 shares | Form 144 ↗ |
| Mar 3, 2025 | Louis H. Morrone Officer | ABT Abbott Laboratories | 1,111 | $153.5K | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 1,111 shares | Form 144 ↗ |
| Mar 3, 2025 | Mary K. Moreland Officer | ABT Abbott Laboratories | 791 | $109.3K | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 791 shares | Form 144 ↗ |
| Mar 3, 2025 | John A. McCoy, Jr. Officer | ABT Abbott Laboratories | 562 | $77.7K | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 562 shares | Form 144 ↗ |
| Feb 5, 2025 | Robert B. Ford Officer | ABT Abbott Laboratories | 285,388 | $37.4M | — | Feb 5, 2025 | Form 4 ↗ 2 days later · 285,388 shares | Form 144 ↗ |
| Jan 30, 2025 | Hubert L. Allen Officer | ABT Abbott Laboratories | 58,428 | $7.5M | — | Jan 30, 2025 | Form 4 ↗ 1 day later · 189,788 shares | Form 144 ↗ |
| Jan 30, 2025 | Daniel Gesua Sive Salvadori Officer | ABT Abbott Laboratories | 23,771 | $3.1M | — | Jan 30, 2025 | Form 4 ↗ 1 day later · 23,771 shares | Form 144 ↗ |
| Jan 29, 2025 | Hubert L. Allen Officer | ABT Abbott Laboratories | 131,360 | $16.9M | — | Jan 29, 2025 | Form 4 ↗ 2 days later · 189,788 shares | Form 144 ↗ |
| Nov 4, 2024 | Funck, Jr. Robert E. Officer | ABT Abbott Laboratories | 15,000 | $1.8M | 10b5-1 | Nov 4, 2024 | — | Form 144 ↗ |
| Oct 21, 2024 | Hubert L. Allen Officer | ABT Abbott Laboratories | 157,421 | $18.7M | 10b5-1 | Oct 21, 2024 | Form 4 ↗ 2 days later · 157,421 shares | Form 144 ↗ |
| Sep 12, 2024 | Robert B. Ford Officer | ABT Abbott Laboratories | 141,679 | $16.5M | — | Sep 12, 2024 | — | Form 144 ↗ |
| Sep 4, 2024 | Funck, Jr. Robert E. Officer | ABT Abbott Laboratories | 30,000 | $3.5M | 10b5-1 | Sep 4, 2024 | — | Form 144 ↗ |
| May 10, 2024 | Funck, Jr. Robert E. Officer | ABT Abbott Laboratories | 10,097 | $1.5M | — | May 10, 2024 | — | Form 144 ↗ |
| May 7, 2024 | Lisa D. Earnhardt Officer | ABT Abbott Laboratories | 22,852 | $2.4M | — | May 7, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Daniel Gesua Sive Salvadori Officer | ABT Abbott Laboratories | 963 | $114.1K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Louis H. Morrone Officer | ABT Abbott Laboratories | 801 | $94.9K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Mary K. Moreland Officer | ABT Abbott Laboratories | 676 | $80.1K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | John A. McCoy, Jr. Officer | ABT Abbott Laboratories | 472 | $55.9K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Lisa D. Earnhardt Officer | ABT Abbott Laboratories | 694 | $82.2K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Hubert L. Allen Officer | ABT Abbott Laboratories | 853 | $101.1K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Feb 23, 2024 | Andrea F. Wainer Officer | ABT Abbott Laboratories | 12,500 | $1.5M | 10b5-1 | Feb 23, 2024 | — | Form 144 ↗ |
| Jan 29, 2024 | Andrea F. Wainer Officer | ABT Abbott Laboratories | 42,500 | $4.8M | 10b5-1 | Jan 29, 2024 | — | Form 144 ↗ |
| Dec 14, 2023 | Andrea F. Wainer Officer | ABT Abbott Laboratories | 15,000 | $1.6M | 10b5-1 | Dec 14, 2023 | — | Form 144 ↗ |
| Oct 26, 2023 | Daniel J. Starks Director | ABT Abbott Laboratories | 50,000 | $4.7M | 10b5-1 | Oct 26, 2023 | — | Form 144 ↗ |
| Aug 8, 2023 | Andrea F. Wainer Officer | ABT Abbott Laboratories | 10,400 | $1.1M | 10b5-1 | Aug 8, 2023 | — | Form 144 ↗ |
| Jul 27, 2023 | Daniel J. Starks Director | ABT Abbott Laboratories | 50,000 | $5.7M | 10b5-1 | Jul 27, 2023 | — | Form 144 ↗ |
| Jul 26, 2023 | Karam Sammy Affiliate | ABT Abbott Laboratories | 17,324 | $2.0M | 10b5-1 | Jul 25, 2023 | — | Form 144 ↗ |
| Jun 16, 2023 | Philip P. Boudreau Officer | ABT Abbott Laboratories | 8,000 | $848.0K | 10b5-1 | Jun 16, 2023 | — | Form 144 ↗ |
| May 2, 2023 | Daniel J. Starks Director | ABT Abbott Laboratories | 50,000 | $5.6M | 10b5-1 | May 2, 2023 | — | Form 144 ↗ |
| May 2, 2023 | Randel Woodgrift Senior Vice President | ABT Abbott Laboratories | 32,000 | $3.6M | — | May 2, 2023 | — | Form 144 ↗ |
| May 2, 2023 | Andrea Wainer Executive Vice President | ABT Abbott Laboratories | 8,226 | $909.5K | — | May 2, 2023 | — | Form 144 ↗ |
| May 2, 2023 | Joseph J. Manning Executive Vice President | ABT Abbott Laboratories | 4,500 | $499.6K | — | May 2, 2023 | — | Form 144 ↗ |
50 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances